FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Medical product themed three picture collage. It contains the white FDA logo in the upper right corner.](https://public4.pagefreezer.com:443/content/FDA/09-03-2023T12:04/https://www.fda.gov/files/styles/medium_3/public/Generic%20Drugs%202022_CU_1600x900_V3.png?itok=tDGk4nuS)
Collaboration and Scientific Innovation Stimulated Advancement in the Generic Drug Program in 2022
In 2022, FDA had a very productive year with the approval of hundreds of generic drugs.
![Photo collage image: Upper left image of pregnant woman feeding child. Center image of Dr. Califf. Upper center image of pill bottle with pills spilling out. Lower center image of researcher in lab. Right image of entrance of FDA Headquarters.](https://public4.pagefreezer.com:443/content/FDA/09-03-2023T12:04/https://www.fda.gov/files/styles/medium_3/public/Califf_anniversary_1600x900.png?itok=7PGfF2BN)
The Work of FDA Continues in Thousands of Workstreams that Americans and the World Count on Every Day
This FDA Voices is part two of FDA Commissioner Robert M. Califf's reflection on his one-year anniversary at the agency.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|